To update the case-fatality rate (CFR) associated with invasive aspergillosis according to
underlying conditions, site of infection, and antifungal therapy, data were systematically …

Hemoptysis is frequently encountered in clinical practice, and may be the presenting
symptom of a number of diseases. Although massive hemoptysis accounts for only 5–15% of …

We describe 18 nonimmunocompromised patients with chronic pulmonary aspergillosis.
Duration of the disease ranged from several months to> 12 years. All 18 patients had prior …

Aspergillus is a genus of fungi commonly found in all environments. Remarkably, only a few
species cause disease and equally remarkably, those same species cause multiple …

Objectives: The purpose of this retrospective study is to analyze the results of the surgical
treatment for pulmonary aspergilloma and to confirm that aggressive surgical resection can …

Aspergillus fungus is a ubiquitous saprophyte that is the causative organism for the
development of an aspergilloma. The most common species causing an aspergilloma is the …

Pulmonary aspergillosis encompasses a heterogeneous group of mycoses that result from
either colonisation or pathogenic damage of lung tissue by Aspergillus fungi. These clinical …

BACKGROUND: The optimal treatment strategy for pulmonary aspergilloma (PA) remains
controversial. Among a variety of options, surgical removal of the mycetoma is considered …

Voriconazole is the second oral drug licensed for the treatment of aspergillosis. A
retrospective non-comparative study was conducted in 16 patients with chronic cavitary …

Aspergillus is a ubiquitous fungus. It is commonly isolated as an upper respiratory tract
saprophyte and is the most frequent contaminant in laboratory specimens. Because species …